Reversal of Immunity After Clearance of Chronic HCV Infection-All Reset?
- PMID: 33133084
- PMCID: PMC7578424
- DOI: 10.3389/fimmu.2020.571166
Reversal of Immunity After Clearance of Chronic HCV Infection-All Reset?
Abstract
Chronic viral infections cause deterioration of our immune system. However, since persistent infections rarely can be eliminated, the reinvigoration capacity of an exhausted immune system has remained largely elusive. Chronic hepatitis C virus (HCV) infection can since some years be effectively cured with novel direct acting antiviral agents. Thus, it is now possible to study reversal of immunity in patients that are cured from a long-lasting chronic infection. We here highlight recent developments in the analysis of various immune cell populations during and after clearance of HCV infection. Surprisingly, whereas reinvigoration of certain immune traits clearly can be seen, many features of immune exhaustion persist over time after viral elimination. Thus, a long-term chronic insult might result in irreversible damage to our immune system. This will be important to consider in therapeutic vaccination efforts against chronic infection and in the development of immunotherapy based strategies against cancer.
Keywords: MAIT cell; T cell; chronic infection; direct acting antivirals; hepatitis C; natural killer cell; soluble inflammatory mediators.
Copyright © 2020 Wedemeyer, Khera, Strunz and Björkström.
Figures

Similar articles
-
Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.J Hepatol. 2019 Nov;71(5):889-899. doi: 10.1016/j.jhep.2019.06.025. Epub 2019 Jul 8. J Hepatol. 2019. PMID: 31295532
-
Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.Eur J Immunol. 2016 Sep;46(9):2204-10. doi: 10.1002/eji.201646447. Epub 2016 Jul 12. Eur J Immunol. 2016. PMID: 27296288
-
Successful direct-acting antiviral therapy improves circulating mucosal-associated invariant T cells in patients with chronic HCV infection.PLoS One. 2020 Dec 31;15(12):e0244112. doi: 10.1371/journal.pone.0244112. eCollection 2020. PLoS One. 2020. PMID: 33382729 Free PMC article. Clinical Trial.
-
Reversal of T Cell Exhaustion in Chronic HCV Infection.Viruses. 2020 Jul 25;12(8):799. doi: 10.3390/v12080799. Viruses. 2020. PMID: 32722372 Free PMC article. Review.
-
Immunology of hepatitis C virus infections.Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):391-400. doi: 10.1016/j.bpg.2012.09.005. Best Pract Res Clin Gastroenterol. 2012. PMID: 23199499 Review.
Cited by
-
Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response.Clin Exp Med. 2025 Jul 30;25(1):269. doi: 10.1007/s10238-025-01811-y. Clin Exp Med. 2025. PMID: 40739075 Free PMC article. Review.
-
Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report.World J Hepatol. 2024 Feb 27;16(2):286-293. doi: 10.4254/wjh.v16.i2.286. World J Hepatol. 2024. PMID: 38495284 Free PMC article.
-
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C.J Infect Dis. 2022 Aug 26;226(3):441-452. doi: 10.1093/infdis/jiab048. J Infect Dis. 2022. PMID: 33517457 Free PMC article.
-
Viral hepatitis update: Progress and perspectives.World J Gastroenterol. 2021 Jul 14;27(26):4018-4044. doi: 10.3748/wjg.v27.i26.4018. World J Gastroenterol. 2021. PMID: 34326611 Free PMC article. Review.
-
HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients.Front Immunol. 2021 Aug 23;12:723196. doi: 10.3389/fimmu.2021.723196. eCollection 2021. Front Immunol. 2021. PMID: 34497613 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources